Nature | Chemistry Follow Thalidomide and targeted protein degradation Connor Delaney traces the chemical legacy of thalidomide, from the regulatory disaster of the 1960s to the first FDA approval of a PROTAC in 2026. https://www.nature.com/articles/s41557-026-02234-2 nature.com
